← Back to Search

Screening Models for Osteoporosis in Male Veterans (MOPS Trial)

N/A
Waitlist Available
Led By Cathleen S Colon-Emeric, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
PACT Team inclusion criteria: Care for male Veterans >65 years (i.e., Women's Health PACTs are excluded)
Patient Inclusion criteria: No prior fracture or osteoporosis diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up year 5
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing different care models for osteoporosis screening in male veterans, to see which is most effective in terms of patient, provider, and facility outcomes.

Who is the study for?
This trial is for male veterans aged 65-85 who have not been diagnosed with osteoporosis or had a fracture, are part of a PACT team led by a provider with at least 0.75 FTE and training, have been enrolled in an eligible PACT team for over two years, and meet one or more VA risk factors for osteoporosis.
What is being tested?
The study is testing the effectiveness of a primary osteoporosis screening care model within the VA healthcare system. It will evaluate outcomes related to patients, providers, and facilities to determine how well each intervention works.
What are the potential side effects?
Since this trial focuses on screening models rather than medication or invasive procedures, there are no direct side effects associated with the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a male Veteran over 65 receiving care.
Select...
I have never been diagnosed with a fracture or osteoporosis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~year 5
This trial's timeline: 3 weeks for screening, Varies for treatment, and year 5 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Bone Mineral Density (gram/sq centimeter)
Harms (%)
Medication Discontinuation (days)
+4 more
Secondary study objectives
Bone Disease Clinic Volume (Consults per year)
DXA volume (DEXA rate per year)
Fractures (% with fracture in last 2 years)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Bone Health Service armExperimental Treatment1 Intervention
Interventional arm
Group II: Usual care (control) armActive Control1 Intervention
This arm represents a "no practice management support" control group.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,765 Total Patients Enrolled
5 Trials studying Osteoporosis
57,366 Patients Enrolled for Osteoporosis
Cathleen S Colon-Emeric, MDPrincipal InvestigatorDurham VA Medical Center, Durham, NC

Media Library

Bone Health Service Model Clinical Trial Eligibility Overview. Trial Name: NCT04079868 — N/A
Osteoporosis Research Study Groups: Bone Health Service arm, Usual care (control) arm
Osteoporosis Clinical Trial 2023: Bone Health Service Model Highlights & Side Effects. Trial Name: NCT04079868 — N/A
Bone Health Service Model 2023 Treatment Timeline for Medical Study. Trial Name: NCT04079868 — N/A
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top